Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigen
- 29 February 1996
- Vol. 47 (2), 212-217
- https://doi.org/10.1016/s0090-4295(99)80419-1
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Long-term Survival and Mortality in Prostate Cancer Treated with Noncurative IntentJournal of Urology, 1995
- Combination of screening and preoperative endocrine therapy: the potential for an important decrease in prostate cancer mortalityJournal of Clinical Endocrinology & Metabolism, 1995
- A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancerPublished by American Medical Association (AMA) ,1995
- Cancer statistics, 1995CA: A Cancer Journal for Clinicians, 1995
- Influence of Benign Prostatic Hyperplasia, Testosterone and age on Serum Levels of Prostate Specific AntigenScandinavian Journal of Urology and Nephrology, 1994
- High 10-year survival rate in patients with early, untreated prostatic cancerPublished by American Medical Association (AMA) ,1992
- Deferred Treatment in Clinically Localised Prostatic CarcinomaBritish Journal of Urology, 1992
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- The palpable nodule of prostatic cancer. Results 15 years after radical excisionJAMA, 1968